Sun Yat-sen University | China.

Author Profile

🎓EARLY ACADEMIC PURSUITS

Prof. Lang Bu’s academic journey began with a focus on innate immunity, virus infections, and liver cancer, laying the foundation for groundbreaking research in signal transduction and tumor microenvironment. His passion for molecular biology and protein modifications has driven his career in precision medicine. His early education in these areas led him to specialize in innovative therapeutic strategies for combating cancer and viral diseases.

💼PROFESSIONAL ENDEAVORS

Prof. Bu currently serves as an Associate Researcher at the Institute of Precision Medicine in Sun Yat-sen University, where he contributes to cutting-edge research on innate immunity and viral infection. His professional experience spans consultancy projects and leadership in high-impact research. His work extends to industry collaborations, underscoring his connection between academic research and practical applications.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON IMMUNITY

Prof. Bu’s research has significantly contributed to the understanding of tumor immunology, particularly focusing on innate immunity, viral infections, and liver cancer. He utilizes advanced techniques to explore signal transduction pathways and immune response mechanisms. His work in post-translational modifications and DNA sequencing has paved the way for personalized treatments, offering insights into innovative therapeutic approaches for cancer and infectious diseases.

🌍IMPACT AND INFLUENCE

Prof. Bu’s research has influenced the fields of viral immunity, tumor biology, and cancer immunotherapy. With significant contributions to global health through published works in SCI and Scopus journals, his influence extends into clinical and global health solutions. Prof. Bu’s findings aim to address critical health issues, particularly in liver cancer and virus-related diseases, ensuring impactful global influence.

📚ACADEMIC CITES

Prof. Bu has a citation index of PMID: 39255795, with 18 published journals in SCI and Scopus-indexed journals. His work has established him as a respected researcher in the areas of innate immunity and virus infection, positioning him as a key figure in advancing the scientific community’s understanding of these critical areas.

🏆RESEARCH GRANTS AND FUNDING

Prof. Bu has successfully secured research funding to support his work in tumor microenvironment and genomic technologies. His ability to attract substantial research grants has enabled further exploration into personalized cancer therapies and advanced immunotherapies, advancing the application of precision medicine.

🛡️LEGACY AND FUTURE CONTRIBUTIONS

Prof. Bu’s legacy is grounded in advancing immune-based therapies and enhancing our understanding of tumor immunity. His ongoing research into innate immunity and viral infection mechanisms is expected to contribute to groundbreaking therapeutic strategies for cancer and infectious diseases.

📑NOTABLE PUBLICATIONS

“Targeting APT2 improves MAVS palmitoylation and antiviral innate immunity”

Authors: Bu, L., Wang, H., Zhang, S., Cheng, C., Guo, J.
Publication Year: 2024
Journal: Molecular Cell
Citations: 2

“High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT”

Authors: Bu, L., Zhang, Z., Chen, J., Kuang, M., Guo, J.
Publication Year: 2024
Journal: Gut
Citations: 19

“Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis”

Authors: Gao, B., Wu, X., Bu, L., Xie, W., Guo, J.
Publication Year: 2024
Journal: Science Advances
Citations: 3

“AMPK phosphorylates and stabilises copper transporter 1 to synergise metformin and copper chelator for breast cancer therapy”

Authors: Zhang, X., Jiang, Q., Su, Y., Xie, W., Guo, J.
Publication Year: 2023
Journal: British Journal of Cancer
Citations: 9

“AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis”

Authors: Sun, Z., Jiang, Q., Gao, B., Li, J., Guo, J.
Publication Year: 2023
Journal: Cancer Research
Citations: 11

Ms. Ziyi Wang | Immunology of Infections | Best Researcher Award

Ms. Ziyi Wang, Wenzhou Medical University, China.

Ms. Ziyi Wang is a researcher specializing in the immunology of infections, with a focus on understanding how the immune system responds to various pathogens. Currently pursuing a Master’s degree in Epidemiology and Medical Statistics at Wenzhou Medical University, she has made significant contributions to the study of infection-related biomarkers and immune responses. Ziyi’s research has earned her the Best Researcher Award, recognizing her innovative work in identifying immune mechanisms and biomarkers that could inform better diagnostics and treatments for infectious diseases. Her dedication to advancing the field has led to her publication of multiple research articles in peer-reviewed journals.

Professional Profiles

Scopus Profile

📚Education

Ms. Ziyi Wang is currently pursuing a Master’s degree in Epidemiology and Medical Statistics at Wenzhou Medical University in Wenzhou, Zhejiang, China. Her academic focus includes researching biomarkers related to diabetes and its complications, particularly in the context of diabetic retinopathy. She has gained a strong foundation in statistical analysis, epidemiological research methods, and disease modeling, with an emphasis on applying these skills to medical and public health issues. Her studies also integrate practical research experience, contributing to her ongoing work in diabetes-related research.

💼Experience

Ms. Ziyi Wang is currently conducting research on biomarkers for diabetic retinopathy (DR), with a specific focus on the role of plasma OA levels. Her work aims to investigate how OA levels could serve as a potential biomarker for early detection and effective management of DR, a common and vision-threatening complication of diabetes. By employing various statistical methods and analytical approaches, her research seeks to better understand the relationship between OA levels and DR risk, contributing to improved diagnostic models and potential clinical interventions for patients with diabetes.

🔬Research Interest

Ms. Ziyi Wang’s research interests focus on biomarkers for diabetic retinopathy (DR), with a particular emphasis on their potential for early detection and effective management of the condition. She is dedicated to exploring the underlying mechanisms of diabetes complications and how specific biomarkers can be utilized for improved diagnosis and treatment. Additionally, her research seeks to identify and explore new treatment targets for DR, aiming to contribute to the development of more targeted and effective therapeutic strategies for managing this vision-threatening complication of diabetes.

👩‍🏫Technical Skills

Ms. Ziyi Wang is proficient in a wide range of technical skills, including statistical analysis, epidemiological modeling, and biomarker detection. She applies advanced statistical methods to analyze complex data and model disease patterns, particularly in the context of diabetes and its complications. Her expertise in biomarker detection allows her to identify key indicators that contribute to the early detection and management of conditions like diabetic retinopathy. Additionally, Ziyi is well-versed in various research methodologies, ensuring the rigorous design, execution, and analysis of her studies to produce reliable and impactful scientific results.

🎤Academic Citations

Ms. Ziyi Wang has published three articles in academic journals, making significant contributions to the field of diabetes research, particularly in the area of biomarkers for diabetic complications. Her research focuses on identifying key biomarkers that can aid in the early detection and management of diabetes-related complications, such as diabetic retinopathy. These publications have helped expand the understanding of the role of biomarkers in diabetes and have provided valuable insights into potential diagnostic tools and treatment strategies, further advancing the knowledge in this critical area of medical research.

📑Top Note Publications

Title: The risk of dyslipidemia on PLHIV associated with different antiretroviral regimens in Huzhou

Authors: Wang, Y., Yang, Z., Li, J., Jin, M., Mao, G.
Publication Year: 2024
Citations: 0

Title: Impact of sarcosine on diabetic retinopathy: Findings based on weighted gene co-expression network analysis and machine learning techniques

Authors: Che, M., Xia, Z., Jiang, D., Zheng, C., Mao, G.
Publication Year: 2023
Citations: 0

Title: Title: Anemia is independently associated with mortality in people living with human immunodeficiency virus/acquired immune deficiency syndrome: A propensity score matching-based retrospective cohort study in China

Authors: Jin, M., Wang, Y., Li, J., Yang, Z., Mao, G.
Publication Year: 2023
Citations: 3

Prof. Lang Bu | Immunity | Best Researcher Award